Information

IMPORTANT: We appreciate your interest in this survey. Your participation is very important to us, and we value your time. Completing this survey will take between 15-25 minutes, depending on your answers. The Survey Monkey system is set up to allow only one visit per computer to the survey. It also DOES NOT permit a participant to begin the survey, leave the website for a while, and return to complete the rest of the questionnaire. If you are having an especially painful day that might not allow you to complete the survey, it is a good idea to wait until a better time to commit to your participation. If you need to come back at another time, please exit now without proceeding so that you will be will still be eligible to complete the survey later. Thank you.

INTRODUCTION

On October 6, 2014, hydrocodone (i.e., Vicodin, Lorcet, Lortab) was moved from a Schedule III opioid medication to a Schedule II opioid medication of the U.S. Controlled Substances Act. This means that stricter regulations by the U.S. Drug Enforcement Administration must be followed by doctors and pharmacists in prescribing and filling these medications. We would like your input regarding whether this has had an impact on your care.

Participation in this survey is completely voluntary. No identifying information is collected. It is your opportunity to make your voice count in a way that may affect policy for millions of people affected by chronic pain. Your participation will help us to better understand the current limitations placed on pain patients in filling their hydrocodone prescriptions. But you don't have to complete the survey if you don't want to. Please read the information below before deciding if you want to participate.

PURPOSE OF THE SURVEY

This is the first of two surveys to learn about the impact new Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) regulations have on people who rely (or relied) on opioid pain prescriptions such as hydrocodone medications to control their chronic pain condition. The purpose of this survey is to see how the rescheduling of hydrocodone has affected patients with chronic pain. You are encouraged to take part in both surveys because cohesive information from the same group of responders will provide a better picture of how these regulations are affecting chronic pain patients’ rights to care. At the end of the survey is a voluntary opportunity to receive email notice of future surveys.

Stricter hydrocodone regulations have changed how doctors prescribe this type of medication for their chronic pain patients. While pharmacists have had the responsibility since 1970 to ensure that a prescription is legal and appropriate, as well as the ability to decline to fill it if they think it is not, it now appears they are being more aggressive in making those determinations. This survey can help answer the questions of: (1) how this new regulation has affected access to hydrocodone medications for people who have been reliant on their help in living with chronic pain; and (2) the effects of pharmacists deciding not to fill prescriptions written by prescribers who are caring for their patients.

Thank you for participating in this survey sponsored by the National Fibromyalgia & Chronic Pain Association (NFMCPA). They can be reached at 1-801-200-36271-801-200-3627 or by email at info@fmcpaware.org.

SUBJECTS

Inclusion Requirements:
You are being asked to participate in this survey if hydrocodone medications were prescribed for you (i.e., Lortab, Vicodin, Lorcet) for the treatment of chronic pain in the past two years.

Exclusion Requirements:
You will not be able to participate in this survey if you have not been prescribed hydrocodone (i.e., Lortab, Vicodin, Lorcet) for the treatment of chronic pain

Question Title

* 1. Are you 18 years of age or older?

T